Health-related biotechnology in Brazil - some regulatory and ethical considerations
by Marilia Bernardes Marques
International Journal of Biotechnology (IJBT), Vol. 5, No. 1, 2003

Abstract: The main purpose of this article is to present an overview of the complex regulatory and ethical challenges associated with the expansion of health-related biotechnology in Brazil. Initially, the author presents the general characteristics of Brazil, a developing Latin American country. The general panorama of human health-related biotechnology in the country is addressed. Finally, the author develops some regulatory and ethical considerations. To conclude, the author stresses optimistically that the current growth-spurt of a bioethics regulatory framework in Brazil is affecting positively the coherence and consistency of local science and health policies.

Online publication date: Sun, 20-Jul-2003

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com